Literature DB >> 7929328

Competitive antagonists bridge the alpha-gamma subunit interface of the acetylcholine receptor through quaternary ammonium-aromatic interactions.

D X Fu1, S M Sine.   

Abstract

We recently demonstrated that conserved tyrosines Tyr198 of the alpha subunit and Tyr117 of the gamma subunit of the acetylcholine receptor stabilize binding of the curariform antagonist dimethyl-d-tubocurarine (DMT). To test the hypothesis that DMT interacts directly with these tyrosines, and therefore bridges the alpha-gamma subunit interface, we introduced point mutations into these key positions and expressed one or both mutant subunits in alpha 2 beta gamma 2 acetylcholine receptors in 293 HEK cells. Binding of DMT, measured by competition against the initial rate of 125I-alpha-bungarotoxin binding, shows high affinity for aromatic mutations, reduced affinity for polar mutations, and lowest affinity for arginine mutations. Similar side chain dependences were observed for both Tyr alpha 198 and Tyr gamma 117, indicating interaction of these residues with two symmetrical chemical groups in DMT. Two more bisquaternary antagonists, pancuronium and gallamine, show side chain dependences similar to that of DMT, indicating that the primary stabilizing interactions are aromatic-quaternary in both subunits. For the rigid ligands DMT and pancuronium, co-expressing mutant alpha and gamma subunits revealed independent contributions by each determinant, but strict independence was not observed for the flexible ligand gallamine. The free energy contributed by each aromatic-quaternary interaction was estimated to be 2-4 kcal/mol, as determined from the free energy difference between aromatic and alkyl hydroxyl mutations. Our results suggest that bis-quaternary competitive antagonists bridge the alpha-gamma subunit interface by fitting into a pocket bounded by tyrosines at positions 198 of the alpha subunit and 117 of the gamma subunit.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors.

Authors:  P G Purohit; R J Tate; E Pow; D Hill; J G Connolly
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

Review 2.  Allosteric activation mechanism of the cys-loop receptors.

Authors:  Yong-chang Chang; Wen Wu; Jian-liang Zhang; Yao Huang
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

3.  Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits.

Authors:  S C Harvey; C W Luetje
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

Review 4.  Nicotinic acetylcholine receptors in health and disease.

Authors:  J Lindstrom
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

5.  A model of the nicotinic receptor extracellular domain based on sequence identity and residue location.

Authors:  I Tsigelny; N Sugiyama; S M Sine; P Taylor
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

6.  Curariform antagonists bind in different orientations to acetylcholine-binding protein.

Authors:  Fan Gao; Nina Bern; Alicia Little; Hai-Long Wang; Scott B Hansen; Todd T Talley; Palmer Taylor; Steven M Sine
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

7.  Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors.

Authors:  C S Yost; B D Winegar
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

8.  Membrane tethering enables an extracellular domain of the acetylcholine receptor alpha subunit to form a heterodimeric ligand-binding site.

Authors:  Z Z Wang; S F Hardy; Z W Hall
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

9.  Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.

Authors:  James P Dilger; Ana Maria Vidal; Man Liu; Claire Mettewie; Takahiro Suzuki; Anh Pham; Deeptankar Demazumder
Journal:  Anesthesiology       Date:  2007-06       Impact factor: 7.892

10.  Rescue of amyloid-Beta-induced inhibition of nicotinic acetylcholine receptors by a peptide homologous to the nicotine binding domain of the alpha 7 subtype.

Authors:  Arthur A Nery; Margaret H Magdesian; Cleber A Trujillo; Luciana B Sathler; Maria A Juliano; Luiz Juliano; Henning Ulrich; Sergio T Ferreira
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.